Connecticut Wealth Management’s Boston Scientific BSX Stock Holding History

Connecticut Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,435	Closed	-$216K	–	343
2026 Q1	$216K	Buy	3,435 +116	+3%	+$9.28K	0.01%	317
2025 Q4	$316K	Sell	3,319 -135	-4%	-$13.2K	0.01%	261
2025 Q3	$337K	Hold	3,454	–	–	0.02%	262
2025 Q2	$371K	Hold	3,454	–	–	0.02%	237
2025 Q1	$348K	Sell	3,454 -78	-2%	-$7.85K	0.02%	241
2024 Q4	$315K	Buy	3,532 +135	+4%	+$11.9K	0.02%	226
2024 Q3	$285K	Buy	3,397 +680	+25%	+$53.6K	0.01%	269
2024 Q2	$209K	Buy	+2,717	New	+$199K	0.01%	308

Other funds holding BSX

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Connecticut Wealth Management's BSX Position: Q2 2026 in Review

Connecticut Wealth Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,435 shares — an estimated $216K sold.

Connecticut Wealth Management first reported a position in BSX in Q2 2024 and held it in 8 quarters. The position peaked at $371K in Q2 2025. 659 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Connecticut Wealth Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Connecticut Wealth Management sold 3,435 Boston Scientific shares in Q2 2026, an estimated $216K.
Connecticut Wealth Management first reported a position in Boston Scientific in Q2 2024 and held it in 8 quarters.
Connecticut Wealth Management's Boston Scientific position peaked at $371K in Q2 2025.
659 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Connecticut Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.